Ixico (IXI)

 

IXI Share PerformanceMore

52 week high44.000 05/12/16
52 week low22.000 04/10/16
52 week change 7.000 (26.92%)
4 week volume40,805 28/08/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

IXICO five-year contract extended

IXICO has signed an extension and expansion to its largest existing contract, which was awarded in August 2015, for a phas...

Extension of a 5 year contract

RNS Number: 7886P IXICO plc 05 September 2017 5 September 2017 IXICO plc ("IXICO" or the "Company") Extension of a 5 year contract in a Phase II/III Alzheimer's Disease clinical trial with a top 10 global pharmaceutical company IXICO plc (AIM: IXI), the digital technologies company serving neuroscience, today announces that it has signed an extension and exp...

Director/PDMR Shareholding

RNS Number: 4442N IXICO plc 08 August 2017 8 August 2017 IXICO plc ("IXICO" or the "Company") Share option grant IXICO plc (AIM: IXI) ('IXICO' or the 'Company'), the digital technologies company serving neuroscience , announces a grant of options over the ordinary shares in the Company in accordance with the rules of the Company's EMI Share Option Pla...

IXICO expands collaboration with Biogen

IXICO, the digital technologies company serving neuroscience, has expanded its pilot of the Assessa PML platform which in...

Expansion of Collaboration with Biogen

RNS Number: 8044L IXICO plc 24 July 2017 24 July 2017 IXICO plc ("IXICO" or the "Company") Expansion of the commercial collaboration with Biogen and expert institutions Further enhancement of IXICO's Assessa PML platform to support pharmacovigilance reporting IXICO plc (AIM: IXI), the digital technologies company serving neuroscience, announces an e...

IXICO hosts Alzheimer expert symposium

IXICO, the digital technologies company serving neuroscience, is holding an expert symposium today on the impact and fu...

IXICO hosts Alzheimer Expert Symposium

RNS Number: 3129L IXICO plc 18 July 2017 18 July 2017 IXICO plc ("IXICO" or the "Company") IXICO hosts Alzheimer Expert Symposium Accelerating the development of treatments for Alzheimer's disease Coinciding with the Alzheimer's Association International Conference in London's Historic Tower Bridge 18 July 2017, IXICO plc (AIM: IXI), the digital technolo...

FTSE rises as GBP dips ahead of UK services PMI

The FTSE is rising in early deals with both the blue-chip and mid-cap indices making cautious headway in early deals as st...

Fundamental DataMore

EPS-8.7
Dividend yield0 %

Equity Research (IXI)

edison investment research
IXICO Plc
02/09/2015
IXICO has secured one of its biggest contracts yet, worth $7m over seven years for clinical trial services. The award supports our investment thesis and financial forecasts, reflecting strong growth...
edison investment research
IXICO Plc
11/06/2015
IXICO sells technologies and services for the analysis of brain disease. We expect strong growth mainly driven by the expansion of its clinical trial business into new indications, new markets and...
edison investment research
IXICO Plc
11/06/2015
IXICO sells technologies and services for the analysis of brain disease. We expect strong growth mainly driven by the expansion of its clinical trial business into new indications, new markets and...

Latest discussion posts More

  • Rollercoaster

    Well, after the news this morning this all but disappeared down the toilet, but then the buyers moved in...... has some support after all. Been an interesting few weeks.
    20-Dec-2016
    Ding2dong
  • Re: Wow

    It would be nice to see 60p by the end of the week, now that it's got a little momentum. Pi
    4-Dec-2016
    pi4
  • Re: Wow

    Lol... I think we'll be joined by a few more if this continues. Surprised coldascheese hasn't reappeared, he was always talking it up.
    2-Dec-2016
    Ding2dong

Users' HoldingsMore

Users who hold Ixico also hold..
LLOYDS GRP.21%
TESCO18%
ROCKHOPPER15%
RANGE RES.15%
BP15%

Codes & Symbols

ISINGB00BCLY7L40
SymbolsIXI, LSE:IXI, IXI.L, IXI:LN, LON:IXI, XLON:IXI